Donna Schora
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
- Clinical Biochemistry top 5%
- Bacterial Identification and Susceptibility Testing
Papers in
-
- Clostridium difficile and Clostridium perfringens research 9
- Antimicrobial Resistance in Staphylococcus 6
-
- Antibiotic Resistance in Bacteria 7
- Co-authors
- Lance R. Peterson (19 shared papers)Ari Robicsek (7 shared papers)Kamaljit Singh (8 shared papers)Parul Patel (9 shared papers)Marc‐Oliver Wright (3 shared papers)Karen L. Kaul (2 shared papers)Kathy A. Mangold (3 shared papers)Barbara L. Voss (2 shared papers)
- Journals
- Journal of Clinical Microbiology (5 papers)American Journal of Infection Control (4 papers)Infection Control and Hospital Epidemiology (3 papers)Open Forum Infectious Diseases (3 papers)Antimicrobial Agents and Chemotherapy (2 papers)
- Partner nations
- United StatesIsraelSerbia
In The Last Decade
Donna Schora
22 papers receiving 317 citations
Peers
Comparison fields: 5 of 49
- Molecular Medicine 113
- Clinical Biochemistry 64
- Endocrinology 49
- Applied Microbiology and Biotechnology 17
- Emergency Medical Services 56
Countries citing papers authored by Donna Schora
This map shows the geographic impact of Donna Schora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna Schora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna Schora more than expected).
Fields of papers citing papers by Donna Schora
This network shows the impact of papers produced by Donna Schora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna Schora. The network helps show where Donna Schora may publish in the future.
Co-authors
The 25 scholars most cited alongside Donna Schora, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 66 | |
| 2 | 2012 | 65 | |
| 3 | 2013 | 49 | |
| 4 | 2016 | 30 | |
| 5 | 2014 | 19 | |
| 6 | 2014 | 18 | |
| 7 | 2016 | 17 | |
| 8 | 2015 | 16 | |
| 9 | 2018 | 9 | |
| 10 | 2015 | 6 | |
| 11 | 2021 | 6 | |
| 12 | 2013 | 6 | |
| 13 | 2013 | 5 | |
| 14 | 2014 | 5 | |
| 15 | 2020 | 5 | |
| 16 | 2014 | 4 | |
| 17 | 2020 | 2 | |
| 18 | 2023 | 1 | |
| 19 | 2018 | 1 | |
| 20 | 2019 | 1 |
About Donna Schora
Donna Schora is a scholar working on Infectious Diseases, Molecular Medicine, Epidemiology, Clinical Biochemistry and Applied Microbiology and Biotechnology, having authored 23 papers that have together received 333 indexed citations. Recurring topics across this work include Clostridium difficile and Clostridium perfringens research (9 papers), Antibiotic Resistance in Bacteria (7 papers), Antimicrobial Resistance in Staphylococcus (6 papers), Bacterial Identification and Susceptibility Testing (5 papers), Antibiotic Use and Resistance (4 papers), Microscopic Colitis (2 papers), Urinary Tract Infections Management (2 papers) and Nosocomial Infections in ICU (2 papers). The work is most often cited by research in Molecular Medicine (113 citations), Clinical Biochemistry (64 citations), Endocrinology (49 citations), Applied Microbiology and Biotechnology (17 citations) and Emergency Medical Services (56 citations). Donna Schora has collaborated with scholars based in United States, Israel and Serbia. Frequent co-authors include Lance R. Peterson, Ari Robicsek, Kamaljit Singh, Parul Patel, Marc‐Oliver Wright, Karen L. Kaul, Kathy A. Mangold, Barbara L. Voss, Mary K. Hayden and Vishnu Chundi. Their work appears in journals such as Journal of Clinical Microbiology, American Journal of Infection Control, Infection Control and Hospital Epidemiology, Open Forum Infectious Diseases and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.